Author:
Mazzone Elio,Briganti Alberto,Montorsi Francesco
Publisher
Springer International Publishing
Reference79 articles.
1. Galper SL, Chen M-H, Catalona WJ, et al. Evidence to support a continued stage migration and decrease in prostate cancer specific mortality. J Urol. 2006;175:907–12.
2. Shao Y-H, Demissie K, Shih W, et al. Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst. 2009;101:1280–3.
3. Reese AC, Wessel SR, Fisher SG, Mydlo JH. Evidence of prostate cancer “reverse stage migration” toward more advanced disease at diagnosis: Data from the Pennsylvania Cancer Registry. Urol Oncol. 2016;34(335):e21–8.
4. Budäus L, Spethmann J, Isbarn H, et al. Inverse stage migration in patients undergoing radical prostatectomy: results of 8916 European patients treated within the last decade. BJU Int. 2011;108:1256–61.
5. Bandini M, Mazzone E, Preisser F, et al. Increase in the annual rate of newly diagnosed metastatic prostate cancer: a contemporary analysis of the surveillance, epidemiology and end results database. Eur Urol Oncol. 2018;1:314–20.